Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.
about
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatumSynergistic dopaminergic neurotoxicity of manganese and lipopolysaccharide: differential involvement of microglia and astroglia.Proteomic analysis of rat microglia establishes a high-confidence reference data set of over 3000 proteins.Impaired inflammatory responses in murine Lrrk2-knockdown brain microglia.The endotoxin-induced neuroinflammation model of Parkinson's disease.Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.LPS-induced proNGF synthesis and release in the N9 and BV2 microglial cells: a new pathway underling microglial toxicity in neuroinflammationDown-regulation of microglial activity attenuates axotomized nigral dopaminergic neuronal cell loss.Aspects of innate immunity and Parkinson's disease.Manganese chloride stimulates rat microglia to release hydrogen peroxideNovel Molecular Insights into Classical and Alternative Activation States of Microglia as Revealed by Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based ProteomicsAdenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.Microglial activation and antioxidant responses induced by the Parkinson's disease protein α-synuclein.Real-time analysis of microglial activation and motility in hepatic and hyperammonemic encephalopathy.Animal models of Parkinson's disease progressionThe lipopolysaccharide Parkinson's disease animal model: mechanistic studies and drug discovery.Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generationStudy on the dynamic changes in synaptic vesicle-associated protein and axonal transport protein combined with LPS neuroinflammation model.Microglial responses to dopamine in a cell culture model of Parkinson's disease.Effects of intravenous human umbilical cord blood CD34+ stem cell therapy versus levodopa in experimentally induced Parkinsonism in mice.Paraquat and Parkinson's disease.Rifampicin and Parkinson's disease.Brain and retinal microglia in health and disease: an unrecognized target of the renin-angiotensin system.Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension.Proteome of brain glia: the molecular basis of diverse glial phenotypes.Role of the dopaminergic system in the development of myopia in children and adolescents.Characterization of a SILAC method for proteomic analysis of primary rat microglia.Spike-In SILAC Approach for Proteomic Analysis of Ex Vivo Microglia.Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.Melatonin Attenuates Manganese and Lipopolysaccharide-Induced Inflammatory Activation of BV2 Microglia.Targeting Microglial Activation States as a Therapeutic Avenue in Parkinson's Disease.The role of the immunoproteasome in interferon-γ-mediated microglial activation.Subchronic infusion of the product of inflammation prostaglandin J2 models sporadic Parkinson's disease in mice.Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats.α-Synuclein Alters Toll-Like Receptor ExpressionComplex II of the mitochondrial respiratory chain is the key mediator of divalent manganese-induced hydrogen peroxide production in microglia.Ischemia-responsive protein 94 is a key mediator of ischemic neuronal injury-induced microglial activation.Modulation of the main porcine enteric neuropeptides by a single low-dose of lipopolysaccharide (LPS) Salmonella Enteritidis.Leucine-Rich Repeat Kinase 2 Controls the Ca2+/Nuclear Factor of Activated T Cells/IL-2 Pathway during Aspergillus Non-Canonical Autophagy in Dendritic Cells.
P2860
Q26861263-0389F4AA-EF70-46A9-B659-BB01F94667BCQ28566901-0E1CA69E-9697-41E3-821E-7F9754807451Q33601778-7B250B4C-6609-4322-8D64-A01D53B1E72CQ34084536-4FCB779B-B6CA-4D10-8A53-C1629DA40F16Q34230271-0CEB2745-9138-4366-BD0B-837CD0A1F67FQ34557246-C9096158-A901-4739-80F0-210D37CE06F9Q34972079-0D6D9426-45A4-44A5-A270-ABD8B2DEF4C6Q34989278-7DE203E5-CDC3-46C5-962E-AC6DFB8027B6Q35007941-57B30FE5-234A-4DDC-B59B-66E752C1088AQ35813131-F6EBA69E-28C5-4028-9C3A-A0F2C642DFD8Q36178038-CEB41EC2-052C-49FA-B78A-840C5A7F9DCCQ36604409-F0392A3C-9214-49D3-AB01-8E33BBB7903EQ36627429-F7D65BD5-492F-453F-94EE-884B21B2909AQ36640417-3C28EC74-9331-4246-AD73-CFB9C616F757Q36670749-B8E18690-465E-4405-B80D-552500A74E6AQ36924624-5C20B9C4-E452-4EF4-846A-E564C8603CAFQ37076726-DAD2749E-EBFB-4ED7-8612-94FDD564A7B3Q37169187-40551959-C6C8-4C76-B711-253749BE3126Q37239733-91AB0A5C-015C-4F9D-B4E5-3CAD9D807E1CQ37389383-B8934C5C-D940-4BDF-89BE-4B452985BBC0Q37517917-99082AA9-1833-43F1-BE67-17BD61C40970Q37679695-8558D484-8B46-4FBD-AA12-638055DAED3EQ38028366-84FDADF4-BAF5-4297-A5D1-7951A33BD898Q38100285-81316B3A-1379-4A41-ADCF-634532D4320BQ38110197-0A09483C-127E-4910-B2FE-16F65998248BQ38152439-DB712FFC-E357-4C4B-83C6-278C52A91D6CQ38226491-D9179043-6E98-4434-AA2D-C32469459012Q38395256-F9BE9845-CCA4-43BA-9994-39982D68F7F8Q38703388-F48EEF5E-A16E-4398-BB17-A7BC7D0CE703Q38713935-C0982E0A-0E5A-4437-A7FF-FC5421F8A21DQ38728319-29CD8D69-2B0B-447A-839D-02058DFB824AQ39392775-B283CFDC-2FEF-46C0-8461-B0129DD37341Q40080281-D23805D7-1D98-441A-8E50-5F66C87FE443Q41955640-6F00EC01-A2FC-441A-A012-D789E6E9FBFFQ42413100-A95AF7B6-1104-4B34-AB32-EE24B8A9D34BQ42783371-4D959286-8B86-4F2A-83A0-E4FE99B0153BQ45763431-2F8E714F-D2BD-482E-B9A0-BCC93BBE591DQ46346051-CBDA34EB-E99A-434C-A860-8D049CAB9C2CQ47097224-326095E6-880B-4EE1-A70C-EB00A60694E5Q50190181-353D63ED-B2DE-459A-B17C-CB35FCA69380
P2860
Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Modulation of microglial pro-i ...... atment of Parkinson's disease.
@ast
Modulation of microglial pro-i ...... atment of Parkinson's disease.
@en
type
label
Modulation of microglial pro-i ...... atment of Parkinson's disease.
@ast
Modulation of microglial pro-i ...... atment of Parkinson's disease.
@en
prefLabel
Modulation of microglial pro-i ...... atment of Parkinson's disease.
@ast
Modulation of microglial pro-i ...... atment of Parkinson's disease.
@en
P2860
P921
P356
P1433
P1476
Modulation of microglial pro-i ...... atment of Parkinson's disease.
@en
P2093
P2860
P2888
P304
P356
10.1208/AAPSJ080369
P407
P577
2006-09-29T00:00:00Z
P5875
P6179
1038414581